Antibodies that bind to human tau and assay for quantifying human tau using the antibodies
US-2016356794-A1 · Dec 8, 2016 · US
Alzheimer's disease; Amyloid plaque core protein
Alzheimer's disease; Amyloid plaque core protein · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/4711 |
| Official title | {Alzheimer's disease; Amyloid plaque core protein} |
| Display label | Alzheimer's disease; Amyloid plaque core protein |
| Total patents | 531 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 46 |
| 2016 | 49 |
| 2017 | 41 |
| 2018 | 63 |
| 2019 | 49 |
| 2020 | 47 |
| 2021 | 52 |
| 2022 | 41 |
| 2023 | 48 |
| 2024 | 40 |
| 2025 | 43 |
| 2026 | 12 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
US-9512191-B2 · Dec 6, 2016 · US
Method for inducing differentiation of pluripotent stem cells into endodermal cells
US-2016326488-A1 · Nov 10, 2016 · US
Immunological methods and compositions for the treatment of alzheimer's disease
US-2016297876-A1 · Oct 13, 2016 · US
Chimeric protein in the treatment of amyloidosis
US-2016264637-A1 · Sep 15, 2016 · US
Cells expressing apolipoprotein e and uses thereof
US-2016251665-A1 · Sep 1, 2016 · US
Amyloid Protofibril Antibodies and Methods of Use Thereof
US-2016251419-A1 · Sep 1, 2016 · US
Targeting immunotherapy for amyloidosis
US-2016243230-A1 · Aug 25, 2016 · US
METHODS OF SYNTHESIZING y-AAPEPTIDES, y-AAPEPTIDE BUILDING BLOCKS, y-AAPEPTIDE LIBRARIES, AND y-AAPEPTIDE INHIBITORS OF Ab40 AGGREGATES
US-2016209422-A1 · Jul 21, 2016 · US
Vaccine for treatment of tautopathy
US-9382303-B2 · Jul 5, 2016 · US
Biological complex specific for Alzheimer's disease detection in vitro and use thereof
US-9377472-B2 · Jun 28, 2016 · US
Method for detecting indicators for determining diseases
US-2016161481-A1 · Jun 9, 2016 · US
Treatment agent for cognitive impairment induced by amyloid beta-protein, therapeutic agent for alzheimer's disease, and treatment method and pathological analysis method related to these
US-2016067306-A1 · Mar 10, 2016 · US
IMMUNOGENIC PRODUCTS BASED ON MUTEIN AMYLOID beta (Abeta) AMINO ACID SEQUENCES AND USES THEREOF
US-2016000891-A1 · Jan 7, 2016 · US
Methods for identifying safe and functional humanized antibodies
US-9221900-B2 · Dec 29, 2015 · US
Immunotherapy for Clearing Pathological Tau Conformers
US-2015368328-A1 · Dec 24, 2015 · US
Oligomer-specific amyloid beta epitope and antibodies
US-9216217-B2 · Dec 22, 2015 · US
Treatment of amyloidoses using myelin basic protein and fragments thereof
US-9217013-B2 · Dec 22, 2015 · US
Compositions and methods related to tauopathy
US-9200068-B2 · Dec 1, 2015 · US
Monoclonal antibody
US-9175094-B2 · Nov 3, 2015 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/4711?
- CPC C07K14/4711 is the Cooperative Patent Classification code for “Alzheimer's disease; Amyloid plaque core protein.”
- How many patents are filed under CPC C07K14/4711 (Alzheimer's disease; Amyloid plaque core protein)?
- Our database includes 531 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/4711 growing?
- Publication counts under this code: 40 in 2024 vs 43 in 2025 (latest complete years).